Abstract:Keywords: biocompatible DNA-encoded library parallel synthesis selenium References 1. Rayman MP . Selenium and human health . Lancet 379(9822), 1256–1268 ( 2012 ).Medline CAS Google Scholar 2. Hou W, Xu H . Incorporating selenium into heterocycles and natural products-from chemical properties to pharmacological activities . J. Med. Chem. 65(6), 4436–4456 ( 2022 ).Medline CAS Google Scholar 3. Wrobel JK, Power R, Toborek M . Biological activity of selenium: revisited . IUBMB Life 68(2), 97–105 ( 2016 ).Medline CAS Google Scholar 4. Leszczynska G, Cypryk M, Gostynski B et al. C5-substituted 2-selenouridines ensure efficient base pairing with guanosine; consequences for reading the NNG-3′ synonymous mRNA codons . Int. J. Mol. Sci. 21(8), 2882 ( 2020 ).Medline CAS Google Scholar 5. Hou W, Dong H, Zhang X, Wang Y, Su L, Xu H . Selenium as an emerging versatile player in heterocycles and natural products modification . Drug Discov. Today 27(8), 2268–2277 ( 2022 ).Medline CAS Google Scholar 6. Alhasan R, Nasim MJ, Jacob C, Gaucher C . Selenoneine: a unique reactive selenium species from the blood of tuna with implications for human diseases . Curr. Pharmacol. Reports. 5(3), 163–173 ( 2019 ).CAS Google Scholar 7. Feng X, Pan L, Qian Z et al. Discovery of selenium-containing STING agonists as orally available antitumor agents . J. Med. Chem. 65(22), 15048–15065 ( 2022 ).Medline CAS Google Scholar 8. Rech TDST, Ribeiro EH, Castro ET et al. Antidepressant potential of a functionalized 3-selanyl benzo[b]furan compound in mice: focus on the serotonergic system . ACS Chem. Neurosci. 14(6), 1181–1192 ( 2023 ).Medline CAS Google Scholar 9. Deng X, Xie B, Li Q et al. Discovery of novel bicyclic phenylselenyl-containing hybrids: an orally bioavailable, potential, and multiacting class of estrogen receptor modulators against endocrine-resistant breast cancer . J. Med. Chem. 65(11), 79 -Abstract Truncated-

Selenophenes: Introducing a New Element into the Core of Non‐Steroidal Estrogen Receptor Ligands

Rational Design and Optimization of Selenophenes with Basic Side Chains As Novel Potent Selective Estrogen Receptor Modulators (serms) for Breast Cancer Therapy.

Prenylflavonoids as nonsteroidal phytoestrogens and related structure-activity relationships.

Design, Synthesis, And Sar Studies Of Heteroarylpyrimidines And Heteroaryltriazines As Cb2r Ligands

Identification and Structure-Activity Relationships of a Novel Series of Estrogen Receptor Ligands Based on 7-Thiabicyclo[2.2.1]hept-2-ene-7-oxide.

Discovery of novel SERMs with a ferrocenyl entity based on the oxabicyclo[2.2.1]heptene scaffold and evaluation of their antiproliferative effects in breast cancer cells.

Thiophene-Core Estrogen Receptor Ligands Having Superagonist Activity

Discovery of Novel Bicyclic Phenylselenyl-Containing Hybrids: an Orally Bioavailable, Potential, and Multiacting Class of Estrogen Receptor Modulators Against Endocrine-Resistant Breast Cancer.

Development of Selective Estrogen Receptor Modulator (Serm)-Like Activity Through an Indirect Mechanism of Estrogen Receptor Antagonism: Defining the Binding Mode of 7-Oxabicyclo[2.2.1]hept-5-ene Scaffold Core Ligands.

Bicyclic Core Estrogens As Full Antagonists: Synthesis, Biological Evaluation and Structure-Activity Relationships of Estrogen Receptor Ligands Based on Bridged Oxabicyclic Core Arylsulfonamides

Selenium: the emerging element in the medicinal chemist's toolkit

Estrogen Receptor Ligands. Part 3: the SAR of Dihydrobenzoxathiin SERMs

X-ray Crystallography Study and Optimization of Novel Benzothiophene Analogs As Potent Selective Estrogen Receptor Covalent Antagonists (sercas) with Improved Potency and Safety Profiles.

Synthesis and Evaluation of Estrogen Receptor Ligands with Bridged Oxabicyclic Cores Containing a Diarylethylene Motif: Estrogen Antagonists of Unusual Structure.

Benzothiophene Derivatives As Selective Estrogen Receptor Covalent Antagonists: Design, Synthesis and Anti-Erα Activities.

Design and synthesis of novel benzothiophene analogs as selective estrogen receptor covalent antagonists against breast cancer

Estrogen Receptor Ligands. Part 10: Chromanes: Old Scaffolds for New SERAMs

Design, synthesis, biological evaluation and molecular docking studies of novel 3-aryl-4-anilino-2H-chromen-2-one derivatives targeting ERα as anti-breast cancer agents

Synthesis and in Vitro Anticancer Activity of 6,7-Methylenedioxy (or 5-Hydroxy-6-methoxy)-2-(substituted Selenophenyl)Quinolin-4-One Analogs

An efficient methodological approach for synthesis of selenopyridines: generation, reactions, anticancer activity, EGFR inhibitory activity and molecular docking studies

Triaryl-Substituted Schiff Bases Are High-Affinity Subtype-Selective Ligands for the Estrogen Receptor